Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- Check7 days agoChange DetectedThe page's revision history now shows Revision: v3.6.3 added and Revision: v3.6.0 removed, indicating a platform update to the study history view. This reflects a backend/system update applied to the page rendering.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating enrollment has ended. The record also shows a new revision version, v3.6.0.SummaryDifference0.2%

- Check28 days agoChange DetectedThe latest revision in the record history is now v3.5.5, replacing v3.5.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check50 days agoChange DetectedNew revision tag v3.5.4 was added and the previous v3.5.3 tag was removed in the record history. This reflects a minor backend update to the page without altering study data or content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s displayed software/version revision label was updated from v3.5.0 to v3.5.3, reflecting a site release rather than any change to the underlying trial record.SummaryDifference0.0%

- Check109 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.0%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.